Completed PHASE3 INTERVENTIONAL 2-arm NCT02773641

Placebo-controlled RCT of Botulinum Toxin A as a Treatment for Provoked Vestibulodynia

Double Blind Placebo-controlled RCT of the Efficacy and Safety of Intramuscular Injections of Botulinum Toxin A as a Treatment for Provoked Vestibulodynia

Sponsor: Karolinska Institutet

Conditions Vulvodynia

Interventions Botulinum Toxin Type A Sterile Saline Solution

Updated 7 times since 2017 Last updated: Aug 13, 2019 Started: May 31, 2016 Primary completion: Jun 30, 2019 Completion: Jun 30, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Vulvodynia and is currently completed. Karolinska Institutet leads this study, which shows 7 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Sep 2019 — Jan 2021 [monthly]

Completed PHASE3

Status: Recruiting → Completed
Jun 2018 — Sep 2019 [monthly]

Recruiting PHASE3

▶ Show 2 earlier versions

Mar 2018 — Jun 2018 [monthly]

Recruiting PHASE3

Status: Not Yet Recruiting → Recruiting
Jan 2017 — Mar 2018 [monthly]

Not Yet Recruiting PHASE3

First recorded

May 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Karolinska Institutet

Data source: Karolinska Institutet

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Stockholm, Sweden